Rockefeller Capital Management
PRME icon

Rockefeller Capital Management’s Prime Medicine PRME Stock Holding History

Rockefeller Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$277K Hold
90,735
– – ﹤0.01% 2474
2026
Q2 		$335K Sell
90,735
-666
-0.7% -$2.21K ﹤0.01% 2295
2026
Q1 		$318K Sell
91,401
-29,990
-25% -$114K ﹤0.01% 2226
2025
Q4 		$421K Buy
121,391
+120,252
+10,558% +$535K ﹤0.01% 1995
2025
Q3 		$6.31K Buy
+1,139
New +$4.63K ﹤0.01% 3807

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Rockefeller Capital Management's PRME Position: Q3 2026 in Review

Rockefeller Capital Management held its Prime Medicine (PRME) position steady in Q3 2026 at 90,735 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2474.

Rockefeller Capital Management first reported a position in PRME in Q3 2025 and has held it in 5 quarters since. The position peaked at $421K in Q4 2025. 125 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Rockefeller Capital Management held 90,735 shares of Prime Medicine worth $277K as of Q3 2026.
  • Rockefeller Capital Management left its Prime Medicine share count unchanged in Q3 2026.
  • Prime Medicine made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2474 holding.
  • Rockefeller Capital Management first reported a position in Prime Medicine in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Prime Medicine position peaked at $421K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.